Postpartum depression pill now available to women, drug maker says
The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.
Dec 15, 2023
0
1
The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.
Dec 15, 2023
0
1
Millions of people in Europe and elsewhere suffer degeneration of joint cartilage in the knee, driving EU research into better treatments.
Dec 8, 2023
0
5
Chronic wounds cost Singapore an estimated SGD$350 million a year, accounting for approximately 0.07% of its Gross Domestic Product (GDP). The amount is a significant economic burden, considering that the country spends 4% ...
Dec 7, 2023
1
0
This article includes an interview with Dr. Androulla Eleftheriou, Executive Director at TIF, and Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation
Dec 4, 2023
0
0
A collaborative study between the A*STAR Infectious Diseases Labs (A*STAR ID Labs) and the University of Massachusetts (UMass) Chan Medical School has uncovered that elevated glycerol levels are responsible for increased ...
Nov 30, 2023
0
3
At what age does an adolescent start thinking as an adult? A new study published this week in Nature Communications presents some of the first definitive evidence that executive function—a set of cognitive skills underlying ...
Oct 31, 2023
0
30
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.
Oct 18, 2023
0
55
Scientists are setting out to collect genetic material from 500,000 people of African ancestry to create what they believe will be the world's largest database of genomic information from the population.
Oct 18, 2023
0
0
Playing a single 18-hole round of golf or completing 6 km of either Nordic walking or regular walking may significantly improve immediate cognitive function in older individuals, according to a recent study published in BMJ ...
Oct 16, 2023
0
0
A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to receive jabs during the COVID-19 pandemic, the Bill & Melinda Gates Foundation ...
Oct 9, 2023
0
58